JP2005511697A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005511697A5 JP2005511697A5 JP2003549353A JP2003549353A JP2005511697A5 JP 2005511697 A5 JP2005511697 A5 JP 2005511697A5 JP 2003549353 A JP2003549353 A JP 2003549353A JP 2003549353 A JP2003549353 A JP 2003549353A JP 2005511697 A5 JP2005511697 A5 JP 2005511697A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- alkoxy
- group
- alkylamino
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 claims 11
- 125000000217 alkyl group Chemical group 0.000 claims 8
- 150000001875 compounds Chemical class 0.000 claims 8
- 125000001475 halogen functional group Chemical group 0.000 claims 6
- -1 —OH Chemical group 0.000 claims 6
- 125000001424 substituent group Chemical group 0.000 claims 5
- 125000004191 (C1-C6) alkoxy group Chemical group 0.000 claims 4
- 125000003342 alkenyl group Chemical group 0.000 claims 4
- 125000003282 alkyl amino group Chemical group 0.000 claims 4
- 208000018737 Parkinson disease Diseases 0.000 claims 3
- 125000004890 (C1-C6) alkylamino group Chemical group 0.000 claims 2
- 125000000304 alkynyl group Chemical group 0.000 claims 2
- 239000003795 chemical substances by application Substances 0.000 claims 2
- 239000003814 drug Substances 0.000 claims 2
- 239000003937 drug carrier Substances 0.000 claims 2
- 125000001072 heteroaryl group Chemical group 0.000 claims 2
- 239000008194 pharmaceutical composition Substances 0.000 claims 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 2
- 125000005862 (C1-C6)alkanoyl group Chemical group 0.000 claims 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims 1
- 125000004414 alkyl thio group Chemical group 0.000 claims 1
- 125000000732 arylene group Chemical group 0.000 claims 1
- 229910052799 carbon Inorganic materials 0.000 claims 1
- 208000015114 central nervous system disease Diseases 0.000 claims 1
- 125000000753 cycloalkyl group Chemical group 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- 0 CC(CC1)CC*1OC Chemical compound CC(CC1)CC*1OC 0.000 description 2
- ULAUZHBRDFKDOF-YHYXMXQVSA-N CC(C)CCNC/C(/C)=C\C Chemical compound CC(C)CCNC/C(/C)=C\C ULAUZHBRDFKDOF-YHYXMXQVSA-N 0.000 description 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US33438501P | 2001-11-30 | 2001-11-30 | |
| PCT/US2002/037915 WO2003048163A1 (en) | 2001-11-30 | 2002-11-26 | [1,2,4]-TRIAZOLE BICYCLIC ADENOSINE A2a RECEPTOR ANTAGONISTS |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009245977A Division JP2010018634A (ja) | 2001-11-30 | 2009-10-26 | ［１，２，４］−トリアゾール二環式アデノシンＡ２ａレセプタアンタゴニスト |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2005511697A JP2005511697A (ja) | 2005-04-28 |
| JP2005511697A5 true JP2005511697A5 (enExample) | 2006-01-12 |
| JP4429724B2 JP4429724B2 (ja) | 2010-03-10 |
Family
ID=23306955
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003549353A Expired - Fee Related JP4429724B2 (ja) | 2001-11-30 | 2002-11-26 | ［１，２，４］−トリアゾール二環式アデノシンＡ２ａレセプタアンタゴニスト |
| JP2009245977A Withdrawn JP2010018634A (ja) | 2001-11-30 | 2009-10-26 | ［１，２，４］−トリアゾール二環式アデノシンＡ２ａレセプタアンタゴニスト |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009245977A Withdrawn JP2010018634A (ja) | 2001-11-30 | 2009-10-26 | ［１，２，４］−トリアゾール二環式アデノシンＡ２ａレセプタアンタゴニスト |
Country Status (18)
| Country | Link |
|---|---|
| US (2) | US6875772B2 (enExample) |
| EP (1) | EP1453836B1 (enExample) |
| JP (2) | JP4429724B2 (enExample) |
| KR (1) | KR20050044600A (enExample) |
| CN (1) | CN1688581A (enExample) |
| AR (1) | AR037681A1 (enExample) |
| AT (1) | ATE358130T1 (enExample) |
| AU (1) | AU2002352933A1 (enExample) |
| CA (1) | CA2468658C (enExample) |
| DE (1) | DE60219196T2 (enExample) |
| ES (1) | ES2283625T3 (enExample) |
| HU (1) | HUP0402324A3 (enExample) |
| IL (1) | IL161573A0 (enExample) |
| MX (1) | MXPA04005158A (enExample) |
| PE (1) | PE20030653A1 (enExample) |
| TW (1) | TW200300689A (enExample) |
| WO (1) | WO2003048163A1 (enExample) |
| ZA (1) | ZA200404168B (enExample) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003048163A1 (en) * | 2001-11-30 | 2003-06-12 | Schering Corporation | [1,2,4]-TRIAZOLE BICYCLIC ADENOSINE A2a RECEPTOR ANTAGONISTS |
| TW200300686A (en) | 2001-11-30 | 2003-06-16 | Schering Corp | Adenosine A2a receptor antagonists |
| KR20040091119A (ko) * | 2002-03-12 | 2004-10-27 | 와이어쓰 | 키랄 1,4-이치환된 피페라진의 제조방법 |
| EP1544200A1 (en) * | 2002-09-24 | 2005-06-22 | Kyowa Hakko Kogyo Co., Ltd. | 1,2,4 -TRIAZOLO 1,5-c PYRIMIDINE DERIVATIVE |
| CN101310724A (zh) * | 2002-12-19 | 2008-11-26 | 先灵公司 | 腺苷A2a受体拮抗剂的应用 |
| US7285550B2 (en) | 2003-04-09 | 2007-10-23 | Biogen Idec Ma Inc. | Triazolotriazines and pyrazolotriazines and methods of making and using the same |
| US20070010522A1 (en) * | 2003-04-09 | 2007-01-11 | Chi Vu | Triazolo[1,5-c]pyrimidines and pyrazolo[1,5-c]pyrimidines useful as a2a adenosine receptor antagonists |
| WO2004092177A1 (en) | 2003-04-09 | 2004-10-28 | Biogen Idec Ma Inc. | Triazolopyrazines and methods of making and using the same |
| EP1633756B1 (en) | 2003-04-09 | 2008-12-24 | Biogen Idec MA Inc. | A2a adenosine receptor antagonists |
| TW200507850A (en) | 2003-07-25 | 2005-03-01 | Kyowa Hakko Kogyo Kk | Pharmaceutical composition |
| WO2006129626A1 (ja) * | 2005-05-30 | 2006-12-07 | Kyowa Hakko Kogyo Co., Ltd. | [1,2,4]トリアゾロ[1,5-c]ピリミジン誘導体の製造法 |
| ATE556712T1 (de) * | 2005-06-07 | 2012-05-15 | Kyowa Hakko Kirin Co Ltd | A2a antagonisten zur behandlung von motorischen störungen |
| US20090124663A1 (en) * | 2005-06-08 | 2009-05-14 | Neurosearch A/S | Novel n-phenyl-piperidine derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| TW200803856A (en) | 2005-09-02 | 2008-01-16 | Mount Cook Biosciences Inc | Method of treating parkinson's disease with diarylmethylpiperazine compounds exhibiting delta receptor agonist activity |
| ES2273599B1 (es) | 2005-10-14 | 2008-06-01 | Universidad De Barcelona | Compuestos para el tratamiento de la fibrilacion auricular. |
| US7615556B2 (en) * | 2006-01-27 | 2009-11-10 | Bristol-Myers Squibb Company | Piperazinyl derivatives as modulators of chemokine receptor activity |
| JP2011513493A (ja) | 2008-03-10 | 2011-04-28 | コーネル ユニバーシティー | 血液脳関門透過性の調節方法 |
| WO2010008775A1 (en) * | 2008-06-23 | 2010-01-21 | Ligand Pharmaceuticals Inc. | Aminopyridopyrazinone derivatives for treating neurodegenerative diseases |
| GB201214106D0 (en) * | 2012-08-07 | 2012-09-19 | Univ Strathclyde | Immunomodulatory compounds |
| WO2017173067A1 (en) | 2016-03-31 | 2017-10-05 | Versi Group, Llc | Delta opioid agonist, mu opioid antagonist compositions and methods for treating parkinson's disease |
| CN106866582A (zh) * | 2017-01-10 | 2017-06-20 | 广州隽沐生物科技有限公司 | 一种氟班色林中间体的制备方法 |
| CN111164084B (zh) * | 2018-06-26 | 2023-05-23 | 浙江春禾医药科技有限公司 | 可用作a2a受体拮抗剂的三唑并三嗪衍生物 |
| US12325708B2 (en) | 2019-05-03 | 2025-06-10 | Nektar Therapeutics | Adenosine 2 receptor antagonists |
| CN114901665B (zh) * | 2019-12-26 | 2025-02-18 | 浙江春禾医药科技有限公司 | 三唑并三嗪衍生物在治疗疾病中的用途 |
| JP7646873B2 (ja) * | 2021-04-23 | 2025-03-17 | チョン クン ダン ファーマシューティカル コーポレイション | アデノシンＡ２ａ受容体アンタゴニストとしての化合物およびこれを含む薬学的組成物 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1264901B1 (it) | 1993-06-29 | 1996-10-17 | Schering Plough S P A | Analoghi eterociclici di 1,2,4-triazolo(15-c)pirimidine ad attivita' antagonista per il recettore a2 dell'adenosina |
| DE69428977T2 (de) * | 1993-07-27 | 2002-07-11 | Kyowa Hakko Kogyo Co., Ltd. | Arzneimittel gegen Parkinsonsche Krankheit |
| IT1277392B1 (it) | 1995-07-28 | 1997-11-10 | Schering Plough S P A | Analoghi eterociclici di 1,2,4-triazolo(1,5-c]pirimidine ad attivita' antagonista per il recettore a2a dell'adenosina |
| AU743910B2 (en) * | 1997-03-24 | 2002-02-07 | Kyowa Hakko Kirin Co., Ltd. | {1,2,4}triazolo{1,5-c}pyrimidine derivatives |
| IT1291372B1 (it) | 1997-05-21 | 1999-01-07 | Schering Plough S P A | Uso di analoghi eterociclici di 1,2,4-triazolo (1,5-c) pirimidine per la preparazione di medicamenti utili per il trattamento delle malattie |
| WO1999043678A1 (en) | 1998-02-24 | 1999-09-02 | Kyowa Hakko Kogyo Co., Ltd. | Remedies/preventives for parkinson's disease |
| CN1328560A (zh) * | 1998-09-22 | 2001-12-26 | 协和发酵工业株式会社 | [1,2,4]三唑并[1,5－c]嘧啶衍生物 |
| US6355653B1 (en) | 1999-09-06 | 2002-03-12 | Hoffmann-La Roche Inc. | Amino-triazolopyridine derivatives |
| JP2002037787A (ja) * | 2000-05-16 | 2002-02-06 | Kyowa Hakko Kogyo Co Ltd | ［１，２，４］トリアゾロ［１，５−ｃ］ピリミジン誘導体の製造法 |
| DE60110219T2 (de) | 2000-05-26 | 2006-03-09 | Schering Corp. | Adenosin a2a rezeptor antagonisten |
| IL160878A0 (en) | 2001-10-15 | 2004-08-31 | Schering Corp | Imidazo (4,3-e)-1,2,4-triazolo (1,5-c) pyrimidines as adenosine a2a receptor antagonists |
| WO2003048163A1 (en) * | 2001-11-30 | 2003-06-12 | Schering Corporation | [1,2,4]-TRIAZOLE BICYCLIC ADENOSINE A2a RECEPTOR ANTAGONISTS |
-
2002
- 2002-11-26 WO PCT/US2002/037915 patent/WO2003048163A1/en not_active Ceased
- 2002-11-26 IL IL16157302A patent/IL161573A0/xx unknown
- 2002-11-26 KR KR1020047007953A patent/KR20050044600A/ko not_active Withdrawn
- 2002-11-26 AT AT02789893T patent/ATE358130T1/de not_active IP Right Cessation
- 2002-11-26 HU HU0402324A patent/HUP0402324A3/hu unknown
- 2002-11-26 MX MXPA04005158A patent/MXPA04005158A/es active IP Right Grant
- 2002-11-26 CA CA002468658A patent/CA2468658C/en not_active Expired - Fee Related
- 2002-11-26 US US10/304,939 patent/US6875772B2/en not_active Expired - Lifetime
- 2002-11-26 CN CNA028239679A patent/CN1688581A/zh active Pending
- 2002-11-26 JP JP2003549353A patent/JP4429724B2/ja not_active Expired - Fee Related
- 2002-11-26 ES ES02789893T patent/ES2283625T3/es not_active Expired - Lifetime
- 2002-11-26 DE DE60219196T patent/DE60219196T2/de not_active Expired - Lifetime
- 2002-11-26 AU AU2002352933A patent/AU2002352933A1/en not_active Abandoned
- 2002-11-26 EP EP02789893A patent/EP1453836B1/en not_active Expired - Lifetime
- 2002-11-27 TW TW091134487A patent/TW200300689A/zh unknown
- 2002-11-27 AR ARP020104562A patent/AR037681A1/es unknown
- 2002-11-28 PE PE2002001149A patent/PE20030653A1/es not_active Application Discontinuation
-
2004
- 2004-05-27 ZA ZA200404168A patent/ZA200404168B/en unknown
- 2004-10-26 US US10/973,642 patent/US7078408B2/en not_active Expired - Lifetime
-
2009
- 2009-10-26 JP JP2009245977A patent/JP2010018634A/ja not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2005511697A5 (enExample) | ||
| JP2005511698A5 (enExample) | ||
| JP2004516314A5 (enExample) | ||
| JP2002517491A5 (enExample) | ||
| JP2005053931A5 (enExample) | ||
| JP2004525179A5 (enExample) | ||
| JP2009502743A5 (enExample) | ||
| JP2007510619A5 (enExample) | ||
| EP2308828A3 (en) | CaSR antagonist | |
| EP3159351A3 (en) | Modified 3'-azido-4'-ethynyl-nucleosides as antiviral agents | |
| JP2004530641A5 (enExample) | ||
| JPH11193282A5 (enExample) | ||
| JPH10130104A5 (enExample) | ||
| CA2438991A1 (en) | Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists | |
| JP2006509749A5 (enExample) | ||
| JP2002543183A5 (enExample) | ||
| JP2006514626A5 (enExample) | ||
| JP2009504748A5 (enExample) | ||
| JP2003503449A5 (enExample) | ||
| JPH10287651A5 (enExample) | ||
| JP2002506864A5 (enExample) | ||
| JP2004509837A5 (enExample) | ||
| JP2008513510A5 (enExample) | ||
| JP2004525178A5 (enExample) | ||
| JP2010507590A5 (enExample) |